GlassScriptPhysician profile
Omar Ahmed
NPI 1689012924
$3,641.19
in general payments reported to CMS, 2019-2025
17 companies · $1,203 in 2025
The $1,203 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2021: $264 · 2022: $455 · 2023: $929 · 2024: $562 · 2025: $1,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,694.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $923.77 | 2021-2025 | Phasix Mesh, Bard 3dmax Mesh, Arista Ah Flexitip |
| Optinose US, INC. | $633.26 | 2021-2025 | |
| Aerin Medical INC. | $563.59 | 2022-2025 | |
| Stryker Corporation | $354.87 | 2019-2022 | |
| Genzyme Corporation | $312.21 | 2023-2025 | |
| Medtronic, INC. | $263.02 | 2025 | Propel |
| Regeneron Healthcare Solutions, INC. | $160.27 | 2022-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $99.71 | 2023-2025 | Takhzyro, Hyqvia, Cuvitru |
| Kerecis Limited | $90.02 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Glaxosmithkline, LLC. | $77.67 | 2023-2025 | Nucala |
| Alk-Abello, INC | $47.87 | 2021-2023 | Ragwitek, Odactra, Grastek |
| Hikma Pharmaceuticals USA | $44.42 | 2023-2025 | Ryaltris |
| Paratek Pharmaceuticals, INC. | $14.95 | 2025 | Xhance |
| Leo Pharma INC. | $14.80 | 2022 | |
| Merck Sharp & Dohme LLC | $14.47 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $14.30 | 2019 | |
| Intersect Ent, INC. | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.